ES2158453T3 - Composicion a base de fosfato sodico revestido para la limpieza del intestino. - Google Patents

Composicion a base de fosfato sodico revestido para la limpieza del intestino.

Info

Publication number
ES2158453T3
ES2158453T3 ES97309126T ES97309126T ES2158453T3 ES 2158453 T3 ES2158453 T3 ES 2158453T3 ES 97309126 T ES97309126 T ES 97309126T ES 97309126 T ES97309126 T ES 97309126T ES 2158453 T3 ES2158453 T3 ES 2158453T3
Authority
ES
Spain
Prior art keywords
sodium phosphate
intestine
cleaning
composition based
phosphate covered
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES97309126T
Other languages
English (en)
Inventor
Thomas Wood
Robert Mccrimlisk
Kenneth Sarnowski
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
CB Fleet Co Inc
Original Assignee
CB Fleet Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by CB Fleet Co Inc filed Critical CB Fleet Co Inc
Application granted granted Critical
Publication of ES2158453T3 publication Critical patent/ES2158453T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/42—Phosphorus; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5015—Organic compounds, e.g. fats, sugars
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
    • A61K9/5047—Cellulose ethers containing no ester groups, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Inorganic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Cosmetics (AREA)
  • Detergent Compositions (AREA)
  • External Artificial Organs (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Saccharide Compounds (AREA)

Abstract

SE DESCRIBE UNA COMPOSICION DE LIMPIEZA DEL INTESTINO DE FOSFATO DE SODIO QUE PRESENTA UN SABOR MEJORADO FRENTE A LAS COMPOSICIONES DE FOSFATO DE SODIO CONVENCIONALES. LA COMPOSICION INCLUYE FOSFATO DE SODIO MONOBASICO FLUIDO Y POLVOS O CRISTALES DE FOSFATO DE SODIO DIBASICO QUE HAN SIDO REVESTIDOS CON AL MENOS UN POLIMERO FORMADOR DE PELICULA DE CALIDAD COMESTIBLE, TAL COMO HIDROXIPROPILHIPROMELOSA O POLIETILENGLICOL.
ES97309126T 1996-11-13 1997-11-13 Composicion a base de fosfato sodico revestido para la limpieza del intestino. Expired - Lifetime ES2158453T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US3087096P 1996-11-13 1996-11-13

Publications (1)

Publication Number Publication Date
ES2158453T3 true ES2158453T3 (es) 2001-09-01

Family

ID=21856440

Family Applications (1)

Application Number Title Priority Date Filing Date
ES97309126T Expired - Lifetime ES2158453T3 (es) 1996-11-13 1997-11-13 Composicion a base de fosfato sodico revestido para la limpieza del intestino.

Country Status (11)

Country Link
US (1) US5997906A (es)
EP (1) EP0872242B1 (es)
AT (1) ATE201824T1 (es)
AU (1) AU731016B2 (es)
CA (1) CA2221011C (es)
DE (1) DE69705106T2 (es)
DK (1) DK0872242T3 (es)
ES (1) ES2158453T3 (es)
GR (1) GR3036302T3 (es)
PT (1) PT872242E (es)
SI (1) SI0872242T1 (es)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6555139B2 (en) 1999-06-28 2003-04-29 Wockhardt Europe Limited Preparation of micron-size pharmaceutical particles by microfluidization
GB9924636D0 (en) * 1999-10-18 1999-12-22 Norgine Bv Laxative preparation
US6946149B2 (en) 2002-04-30 2005-09-20 Braintree Laboratories, Inc. Salt solution for colon cleansing
US8361452B2 (en) * 2002-07-15 2013-01-29 Halow George M Bowel cleansing composition
US20050054611A1 (en) * 2002-09-13 2005-03-10 Mats Lake Composition and method for use in intestinal cleansing procedures
US20040071779A1 (en) * 2002-10-09 2004-04-15 Keiser Dale Arthur Gelled laxative compositions
US7291324B2 (en) * 2002-10-22 2007-11-06 Braintree Laboratories Inc. Method of bowel cleansing
US6996500B2 (en) * 2002-10-30 2006-02-07 Hewlett-Packard Development Company, L.P. Method for communicating diagnostic data
US7049319B2 (en) * 2003-09-23 2006-05-23 Semaan Abboud Colon cleansing composition and method
US7687075B2 (en) 2003-11-19 2010-03-30 Salix Pharmaceuticals, Ltd. Colonic purgative composition with soluble binding agent
WO2005120501A1 (en) 2004-06-04 2005-12-22 Braintree Laboratories, Inc. Method of bowel cleansing
US20060051428A1 (en) * 2004-09-03 2006-03-09 Nelson Ayala Aspartame and citrate flavored phosphate salt laxative
US20070082061A1 (en) * 2005-10-07 2007-04-12 Nelson Ayala Reduction of saltiness with sweeteners
US20070196322A1 (en) * 2005-12-29 2007-08-23 Braintree Laboratories Inc. Method of preparing the colon for virtual colonoscopy
US7985429B2 (en) * 2006-03-03 2011-07-26 C. B. Fleet Company, Inc. Flavored colonic cleansing system
US7998510B2 (en) * 2006-08-17 2011-08-16 C. B. Fleet Company, Inc. Low dose colonic cleansing system
WO2010013993A1 (en) * 2008-08-01 2010-02-04 Titan Petchem (M) Sdn Bhd Halal polymer resins and process for making the same
KR101053731B1 (ko) 2008-10-21 2011-08-02 이문성 용해시간 조절형 장세척제 조성물의 제조방법
US8211417B1 (en) 2009-10-31 2012-07-03 Harry Snady Method of bowel cleansing
KR101210831B1 (ko) * 2012-02-10 2012-12-11 주식회사태준제약 폴리에틸렌글리콜과 비타민 씨를 함유하는 장관 하제 조성물

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4999200A (en) * 1987-12-09 1991-03-12 Marion Laboratories Psyllium tablet composition, method of manufacture and method of use
US5498425A (en) * 1995-03-17 1996-03-12 Block Drug Company, Inc. Phosphosoda buffered saline laxative
AU7056896A (en) * 1995-11-03 1997-05-08 Thomas Julius Borody Improved method for colonic evacuation
AUPN634595A0 (en) * 1995-11-03 1995-11-30 Borody, Thomas Julius Improved method for colonic evacuation
ATE235894T1 (de) * 1996-05-08 2003-04-15 Craig A Aronchick Nichtwässrige abführmittel für den kolon

Also Published As

Publication number Publication date
SI0872242T1 (en) 2001-12-31
DK0872242T3 (da) 2001-09-10
EP0872242A3 (en) 1999-10-20
AU731016B2 (en) 2001-03-22
GR3036302T3 (en) 2001-10-31
CA2221011C (en) 2003-06-24
ATE201824T1 (de) 2001-06-15
CA2221011A1 (en) 1998-05-13
DE69705106D1 (de) 2001-07-12
EP0872242A2 (en) 1998-10-21
US5997906A (en) 1999-12-07
DE69705106T2 (de) 2001-09-20
AU4515197A (en) 1998-05-21
PT872242E (pt) 2001-11-30
EP0872242B1 (en) 2001-06-06

Similar Documents

Publication Publication Date Title
ES2158453T3 (es) Composicion a base de fosfato sodico revestido para la limpieza del intestino.
EP0482554A3 (en) Sticky composition for medical use
CA2159055A1 (en) Compositions containing polyanionic polysaccharides and hydrophobic bioabsorbable polymers
AU3906697A (en) Steam sterilization indicator compositions
AU8690691A (en) Stabilized halogen containing polymer compositions
EP0580861A4 (en) CAPSULE.
EG19136A (en) Polymer compositions.
GB2310164B (en) Multi-layer moulded polymer compositions
FR2751540B1 (fr) Composition pharmaceutique antithrombotique
AU7675291A (en) Highly conductive polymer thick film compositions
EA200000181A1 (ru) Фармацевтические композиции, содержащие витамин d и кальций, их приготовление и терапевтическое применение
SG47345A1 (en) Polymer composition having improved oxidative stability
ES513831A0 (es) "procedimiento para la preparacion de esteres carboxilicos de 6-hidroxi-2-benzotiazolsulfonamida".
ES2028451T3 (es) Un procedimiento de preparacion de una composicion cosmetica.
FR2728783B1 (fr) Prothese d'articulation metatarso-phalangienne totale du premier rayon du pied
ZA917659B (en) Polymer compositions
ZA954655B (en) Novel taxoids their preparation and the pharmaceutical compositions which contain them
ES2159843T3 (es) Derivados de 5,11-dihidrodibenzo(b,e)(1,4)oxazepina y composiciones medicamentosas que los contienen.
DK0685170T3 (da) Ikke-fedtholdigt gellangummismøremateriale
IL117045A0 (en) Substituted 2,3-dihydro-1,4-dioxinopyridines their preparation and pharmaceutical compositions containing them
EP0482833A3 (en) Polymer compositions
ATE133177T1 (de) 3'-deamino-4'-deoxy-4'-amino-8-fluoranthracycli e und verfahren zu ihrer herstellung
FR2668703B3 (fr) Prothese totale de l'articulation du genou.
FI930967A0 (fi) Substituerade 6,7-dihydroimidazo(1,5,4-ef)(1,5)bensodiazepin-6-oner, deras framstaellning och farmaceutiska kompositioner
IL104119A (en) 3-substituted (optionally)-5,5-disubstituted-4-oxo-thiazolidin-2-yliden-1-amino-3-substituted-imidazolidin-2- thion-4- or 5-one or 4,5-dione derivatives their preparation and pharmaceutical compositions comprising them

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 872242

Country of ref document: ES